Senate bill S4303-117

Health, Education, Labor, and Pensions Committee

A bill to provide for a period of exclusivity for first interchangeable biological products.

• Last activity on May 25, 2022

• Introduced May 25, 2022

• By Sen. Kaine, Tim [D-VA]

Support this bill

Main Subject: Health

Interchangeable Biologics Clarity Act

This bill provides a statutory definition for first interchangeable biosimilar biological product and makes other technical changes with respect to the provisions that establish the corresponding periods of market exclusivity.

Senate Actions

IntroReferral
May. 25 2022	Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709-2710)

Library of Congress Actions

IntroReferral
May. 25 2022	Introduced in Senate

Senate bill S4303-117

A bill to provide for a period of exclusivity for first interchangeable biological products.

Promote the cause!

Or use this QR code